# EDGAR Filing Document

**Accession Number:** 0000949858
**File Stem:** 0001193125-23-001896
**Filing Date:** 2023-1
**Character Count:** 2746
**Document Hash:** 92b20bca54be4ed0506072aca1c6e197
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-001896.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0001193125-23-001896

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ACHIEVE LIFE SCIENCES, INC.
- **CENTRAL INDEX KEY:** 0000949858
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 954343413
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 22722 29TH DR. SE
- **STREET 2:** SUITE 100
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98021
- **BUSINESS PHONE:** 425-686-1500

**MAIL ADDRESS:**
- **STREET 1:** 22722 29TH DR. SE
- **STREET 2:** SUITE 100
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ONCOGENEX PHARMACEUTICALS, INC.
- **DATE OF NAME CHANGE:** 20080821

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SONUS PHARMACEUTICALS INC
- **DATE OF NAME CHANGE:** 19950825

**ACHIEVE LIFE SCIENCES, INC.** 

1040 West Georgia Street, Suite 1030

Vancouver, BC V6E 4H1

January 5, 2023

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

---

| | |
|:---|:---|
| Attention: | Ada D. Sarmento |
| Re: | Achieve Life Sciences, Inc. Registration Statement on Form S-3 (File No. 333-269059). |

---

Requested Date: January 9, 2023

Requested Time: 4:00 PM Eastern Time

Ladies and Gentlemen:

Achieve Life Sciences (the "***Registrant***") hereby requests that the Securities and Exchange Commission (the "***Commission***") take appropriate action to declare the above-captioned Registration Statement on Form S**-**3 effective at the "Requested Date" and "Requested Time" set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.

The Registrant hereby authorizes Amanda L. Rose and Steven Jean, both of whom are attorneys with the Registrant's outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Rose at (206) 389-4553 or, in her absence, to Mr. Jean at (212) 430-2634.

\* \* \*

------

---

| | | |
|:---|:---|:---|
| Sincerely, |  |  |
|  | **ACHIEVE LIFE SCIENCES, INC.** | **ACHIEVE LIFE SCIENCES, INC.** |
|  | By: | /s/ John Bencich |
|  |  | John Bencich |
|  |  | Chief Executive Officer |

---

cc: Amanda L. Rose, Esq.

Steven Jean, Esq.

**Fenwick & West LLP**